Publication — IRIC AML with EVI1 rearrangements are characterized by SF3B1 and IKZF1 mutations and distinct expression of MECOM isoforms. Publication date August 1, 2014 Principal Investigators Lavallée VP, Boivin I, Armstrong RN, Lemieux S, Gendron P, Hebert J, Sauvageau G PubMed reference Exp. Hematol. 2014;42(8 Suppl):S44 PubMed ID 25106277 Affiliation Institute for Research in Immunology and Cancer, l’Université de Montréal, Montréal, Quebec, Canada; Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.